IMO the latest announcements place this company on a very sound...

IMO the latest announcements place this company on a very sound footing. The most recent re distribution of the research product should see cashflow very soon and the fact that they are actively out there signing up licence agreements with large players is overwhelmingly favourable.
The volumes are small and dips are opportunities to load up.
I have always been confident of the management (since David King has come on board) and Maria is starting to hit the straps and deliver some results.
A great biotech play with enormous upside I believe.
Don't waver!